Literature DB >> 2547759

Purification and partial amino acid sequence of osteogenin, a protein initiating bone differentiation.

F P Luyten1, N S Cunningham, S Ma, N Muthukumaran, R G Hammonds, W B Nevins, W I Woods, A H Reddi.   

Abstract

Osteogenin was purified from bovine bone matrix and its activity monitored by an in vivo bone induction assay. The purification method utilized extraction of the bone-inducing activity with 6 M urea, followed by chromatography on heparin-Sepharose, hydroxyapatite, and Sephacryl S-200. Active fractions were further purified by preparative sodium dodecyl sulfate gel electrophoresis without reduction. Osteogenin activity was localized in a zone between 30 and 40 kDa. The amino acid sequences of a number of tryptic peptides of the gel-eluted material were determined. Reduction and alkylation of purified osteogenin in 7 M guanidine hydrochloride resulted in the total loss of biological activity. Sodium dodecyl sulfate gel electrophoresis under reducing conditions revealed a broad band with an apparent molecular mass of 22 kDa.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2547759

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

1.  Radiation-sterilized insoluble collagenous bone matrix is a functional carrier of osteogenin for bone induction.

Authors:  R W Katz; G C Felthousen; A H Reddi
Journal:  Calcif Tissue Int       Date:  1990-09       Impact factor: 4.333

2.  Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone.

Authors:  A J Celeste; J A Iannazzi; R C Taylor; R M Hewick; V Rosen; E A Wang; J M Wozney
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

Review 3.  Regulation of bone morphogenetic proteins in early embryonic development.

Authors:  Yukiyo Yamamoto; Michael Oelgeschläger
Journal:  Naturwissenschaften       Date:  2004-10-26

4.  Transforming growth factor-beta: its effect on phenotype reexpression by dedifferentiated chondrocytes in the presence and absence of osteogenin.

Authors:  E T Harrison; F P Luyten; A H Reddi
Journal:  In Vitro Cell Dev Biol       Date:  1992-06

5.  The matrix of endochondral bone differs from the matrix of intramembranous bone.

Authors:  C K Scott; J A Hightower
Journal:  Calcif Tissue Int       Date:  1991-11       Impact factor: 4.333

6.  Subpopulations of marrow stromal cells share a variety of osteoblastic markers.

Authors:  D Benayahu; A Fried; D Zipori; S Wientroub
Journal:  Calcif Tissue Int       Date:  1991-09       Impact factor: 4.333

Review 7.  Structural Biology and Evolution of the TGF-β Family.

Authors:  Andrew P Hinck; Thomas D Mueller; Timothy A Springer
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-12-01       Impact factor: 10.005

8.  Bone morphogenic proteins: applications in spinal surgery.

Authors:  Gerard K Jeong; Harvinder S Sandhu; James Farmer
Journal:  HSS J       Date:  2005-09

Review 9.  Cell sources for bone tissue engineering: insights from basic science.

Authors:  Céline Colnot
Journal:  Tissue Eng Part B Rev       Date:  2011-09-27       Impact factor: 6.389

10.  Identification and characterization of cellular binding proteins (receptors) for recombinant human bone morphogenetic protein 2B, an initiator of bone differentiation cascade.

Authors:  V M Paralkar; R G Hammonds; A H Reddi
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.